From Casetext: Smarter Legal Research

Eurand, Inc. v. Mylan Pharmaceuticals Inc.

United States Court of Appeals, Federal Circuit
Jul 7, 2011
449 F. App'x 35 (Fed. Cir. 2011)

Opinion

Nos. 2011-1399, -1409.

July 7, 2011.

Appeals from the United States District Court for the District of Delaware in case no. 09-MD-2118, Judge Sue L. Robinson.

Before GAJARSA, MAYER, and PROST, Circuit Judges.


ON MOTION


ORDER

Mylan Pharmaceuticals Inc. et al. (Mylan) move for a stay, pending appeal, of the injunction entered by the United States District Court for the District of Delaware on May 24, 2011. Eurand, Inc. et al. oppose. Mylan replies.

The power to stay an injunction pending appeal is part of a court's `"traditional equipment for the administration of justice.'" Nken v. Holder, 129 S.Ct. 1749, 1757 (2009) (citing Scripps-Howard Radio, Inc. v. FCC, 316 U.S. 4, 9-10 (1942)). A stay, however, is not a matter of right but instead an exercise of judicial discretion. Nken, 129 S.Ct at 1761. The party requesting a stay bears the burden of showing that the circumstances justify an exercise of that discretion based on consideration of four factors, the first two of which are the most critical: (1) whether the stay applicant has made a strong showing that he is likely to succeed on the merits; (2) whether the applicant will be irreparably injured absent a stay; (3) whether issuance of the stay will substantially injure the other parties interested in the proceeding; and (4) where the public interest lies. Hilton v. Braunskill, 481 U.S. 770, 776 (1987).

Based on the arguments in the motions papers, and without prejudicing the ultimate disposition of this case by a merits panel, we determine that Mylan has met their burden to obtain a stay, pending appeal, of the district court's injunction in part. We deem it proper to stay the injunction as to Paragraph 3 of the Injunction Order only. Mylan's motion to stay the remainder of the injunction provisions is denied.

Accordingly,

IT IS ORDERED THAT:

The motion for a stay is granted in part.


Summaries of

Eurand, Inc. v. Mylan Pharmaceuticals Inc.

United States Court of Appeals, Federal Circuit
Jul 7, 2011
449 F. App'x 35 (Fed. Cir. 2011)
Case details for

Eurand, Inc. v. Mylan Pharmaceuticals Inc.

Case Details

Full title:IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENT…

Court:United States Court of Appeals, Federal Circuit

Date published: Jul 7, 2011

Citations

449 F. App'x 35 (Fed. Cir. 2011)

Citing Cases

Anesta AG v. Mylan Pharm., Inc.

On July 7, 2011, the Federal Circuit ruled on the merits of the stay motion, denying it in part (prohibiting…